EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

  

Myeloma Patients Europe (MPE), in collaboration with the European Cancer Organisation’s Patient Advisory Committee, held a webinar on Evidence-Based Patient Advocacy on 17 November.

This webinar is included in the MPE Advocate Development Programme (ADP) and was given by Jan Geissler, member of the European Cancer Organisation’s Patient Advisory Committee and founder and CEO of Patvocates.

   

   

You can download the slides of this webinar here.







Recent news

» EHA 2021| Daratumumab plus lenalidomide and dexamethasone (D-Rd) shows overall survival benefit in elderly patients with transplant-ineligible newly diagnosed myeloma

» EHA 2021 | Daratumumab maintenance improves Progression-Free Survival (PFS) after autologous stem cell transplantation in myeloma

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.